Estrogen Receptor Positive Breast Cancer research hub
3 indexed studies · 0 currently recruiting
- active not recruitingPHASE1, PHASE2
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
This study is for post-menopausal women with advanced breast cancer that has grown despite standard hormone treatment. It's testing a new drug, AZD5363, alongside an existing treatment, Fulvestrant, to see if it can stop cancer growth more effectively.
United Kingdom - active not recruiting
Personalised Disease Monitoring in Metastatic Breast Cancer
This study looks at how blood tests could help manage metastatic breast cancer. It aims to see if certain markers in your blood can reliably tell doctors when you might need a scan, potentially reducing unnecessary imaging for patients with stable disease.
Sweden · United Kingdom - active not recruitingPHASE2
A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers
This study looks at whether a short course of oestrogen might slow down specific types of oestrogen receptor-positive (ER+) breast cancer before surgery. Researchers want to understand why some ER+ cancers respond differently to hormones.
Canada